(Australia-NewsWire.Com, August 22, 2018 ) North America Articaine Hydrochloride market is anticipated to grow at 6.43% CAGR from 2018 to 2023 and it is estimated that the North America market was valued at USD 0.28 billion in 2018 and is expected to reach USD 0.38 billion by 2023.
Articaine is a form of an amide local anesthetic that is most commonly used in dentistry. This drug is originally known as carticaine. It has a different molecular structure with a thiophene ring instead of the usual benzene ring present in the other amide anesthetic drugs.
Articaine hydrochloride is an amide local anesthetic which has its major applications in dentistry. Increasing incidence of dental disorders is creating huge scope for the dentists resulting high revenue. The number of patients approaching the dentists is soaring as a result the pressure on the articaine hydrochloride market is rising rapidly resulting in the improvement in the effectiveness of the articaine. In oral surgeries, the use of articaine hydrochloride is the first preference for professionals due to its quicker effect. It is associated with less number of failures and also provides anesthesia in cases where other anesthetics fail.
The North America Articaine Hydrochloride market is segmented on the basis of Application and End User. On the basis of Application, the market is segmented into Infiltration, Nerve Block, and Others. In 2017, the nerve block sub segment was the market leader. On the basis of End User, the market is segmented into Dental Clinics, Hospitals and Academic and Research Institutes. Dental Clinic held the largest share of the end user segment.
On the basis of geography, the Articaine Hydrochloride market can be segmented into various regions namely US and Canada. As of 2017, North America accounted for the second largest share of the Articaine Hydrochloride market.